Influence of ketotifen and conventional antiepileptic drugs on the exploratory and spontaneous locomotor activity in mice

1. Beghi E, Giussani G, Sander JW. The natural history and prognosis of epilepsy. Epileptic Disord. 2015;17(3):243–53.10.1684/epd.2015.0751 Search in Google Scholar

2. Sander JW. The epidemiology of epilepsy rivisited. Curr Opin Neurol. 2008;16:165–70.10.1097/00019052-200304000-00008 Search in Google Scholar

3. Berghi E. Prognosis of first seizure. In: Jallon P, Berg AT, Dulac O, Hauser WA. Prognosis of epilepsies. Montrouge: JohnLibbey; 2003:21–8. Search in Google Scholar

4. Pavlova M. Sudden unexpected death in epilepsy: Assessing the risk factors. Neurology. 2020 28;94(4):e436–e438.10.1212/WNL.0000000000008928 Search in Google Scholar

5. Manford M. Recent advances in epilepsy. J Neurol. 2017;264(8): 1811–24.10.1007/s00415-017-8394-2 Search in Google Scholar

6. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88(3):1183–241.10.1152/physrev.00043.2007 Search in Google Scholar

7. Hu W, Chen Z. The roles of histamine and its receptor ligands in central nervous system disorders: An update. Pharmacol Ther. 2017;175:116–32.10.1016/j.pharmthera.2017.02.039 Search in Google Scholar

8. Schlicker E, Kathmann M. Role of the histamine H3 receptor in the central nervous system. Handb Exp Pharmacol. 2017;241:277–99.10.1007/164_2016_12 Search in Google Scholar

9. Lebois EP, Jones CK, Lindsley CW. The evolution of histamine H₃ antagonists/inverse agonists. Curr Top Med Chem. 2011;11(6):648–60.10.2174/1568026611109060648 Search in Google Scholar

10. Sakai N, Onodera K, Maeyama K, Yanai K, Watanabe T. Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell-deficient W/Wv mice. Life Sci. 1991;48(25):2397–404.10.1016/0024-3205(91)90373-J Search in Google Scholar

11. Mohsen A, Yoshikawa T, Miura Y, Nakamura T, Naganuma F, Shibuya K, et al. Mechanism of the histamine H(3) receptor-mediated increase in exploratory locomotor activity and anxiety-like behaviours in mice. Neuropharmacol. 2014;81:188–94.10.1016/j.neuropharm.2014.02.00324530460 Search in Google Scholar

12. Gerald MC, Richter NA. Studies on the effects of histaminergic agents on seizure susceptibility in mice. Psychopharmacol. 1976; 46(3):277–82.10.1007/BF00421114 Search in Google Scholar

13. Tuomisto L, Tacke U. Is histamine an anticonvulsive inhibitory transmitter? Neuropharmacol. 1986;25(8):955–8.10.1016/0028-3908(86)90029-8 Search in Google Scholar

14. Yokoyama H, Onodera K, Maeyama K, Yanai K, Iinuma K, Tuomisto L, Watanabe T. Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of alpha-fluoromethylhistidine and metoprine. Naunyn Schmiedebergs Arch Pharmacol. 1992;346(1):40–5.10.1007/BF00167568 Search in Google Scholar

15. Yokoyama H, Onodera K, Iinuma K, Watanabe T. Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in mice. Eur J Pharmacol. 1993;234(1):129–33.10.1016/0014-2999(93)90717-V Search in Google Scholar

16. Wyngaarden JB, Seevers MH. The toxic effects of antihistaminic drugs. J Am Med Assoc. 1951;145(5):277–82.10.1001/jama.1951.02920230001001 Search in Google Scholar

17. Churchill JA, Gammon GD. The effect of antihistaminic drugs on convulsive seizures. J Am Med Assoc. 1949;141(1):18–21.10.1001/jama.1949.02910010020004 Search in Google Scholar

18. Yokoyama H, Onodera K, Iinuma K, Watanabe T. 2-Thiazolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice. Pharmacol Biochem Behav. 1994;47(3):503–7.10.1016/0091-3057(94)90151-1 Search in Google Scholar

19. Yasuhara A, Ochi A, Harada Y, Kobayashi Y. Infantile spasms associated with a histamine H1 antagonist. Neuropediatrics. 1998; 29(6):320–1.10.1055/s-2007-973585 Search in Google Scholar

20. Yokoyama H, Iinuma K, Yanai K, Watanabe T, Sakurai E, Onodera K. Proconvulsant effect of ketotifen, a histamine H1 antagonist, confirmed by the use of d-chlorpheniramine with monitoring electroencephalography. Methods Find Exp Clin Pharmacol. 1993; 15(3):183–8. Search in Google Scholar

21. Świąder M, Wielosz M, Czuczwar SJ. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice. Eur Neuropsychopharmacol. 2004;14(4):307–18.10.1016/j.euroneuro.2003.09.005 Search in Google Scholar

22. Świąder M, Wielosz M, Czuczwar SJ. Interaction of astemizole, an H1 receptor antagonist, with conventional antiepileptic drugs in mice. Pharmacol Biochem Behav. 2003;76(1):169–78.10.1016/S0091-3057(03)00212-0 Search in Google Scholar

23. Luszczki JJ, Andres MM, Swiader MJ. Effect of lamotrigine combined with felbamate on the horizontal (ambulatory) activity in mice. Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):235–40. Search in Google Scholar

24. Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children. Drug Safety. 2001;24(2):119–147.10.2165/00002018-200124020-0000311235817 Search in Google Scholar

25. Blain PG, Lane RJM. Neurological disorders. In: DM. Davies, RE. Ferner, H. De Glanville (eds). Davies’s Textbook of Adverse Drug Reactions. 5th ed. London: Chapman and Hall Medical; 1998:591–3. Search in Google Scholar

26. Murphy K, Delanty N. Drug-induced seizures: general principles in assessment, management and prevention. CNS Drugs, 2000;14(2): 135–46.10.2165/00023210-200014020-00004 Search in Google Scholar

27. Świąder M, Świąder K. Influence of astemizole, an H1 receptor antagonist, on the locomotors activity of carbamazepine and valproate in mice. Curr Issues Pharm Med Sci. 2012;25(2):173–5.10.12923/j.2084-980X/25.2/a.13 Search in Google Scholar

28. Tuomisto J, Tuomisto L. Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes. Med Biol. 1980;58(1):33–7. Search in Google Scholar

29. Miyazaki S, Imaizumi M, Onodera K. Effects of thioperamide on the cholinergic system and the step-throuhg passive avoidance test in mice. Methods Find Exp Clin Pharmacol. 1995;17(10):653–8. Search in Google Scholar

30. Provensi G, Costa A, Passani MB, Blandina P. Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse. Neuropharmacol. 2016;109:139–47.10.1016/j.neuropharm.2016.06.01027291828 Search in Google Scholar

31. Bitner RS, Markosyan S, Nikkel AL, Brioni JD. In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer’s disease. Neuropharmacol. 2011;60(2–3):460–6.10.1016/j.neuropharm.2010.10.02621044639 Search in Google Scholar

32. Serafim KR, Kishi MS, Canto-de-Souza A, Mattioli R. H₁ but not H₂ histamine antagonist receptors mediate anxiety-related behaviors and emotional memory deficit in mice subjected to elevated plus-maze testing. Braz J Med Biol Res. 2013;46(5):440–6.10.1590/1414-431X20132770385439823598647 Search in Google Scholar

33. Serafim KR, Gianlorenço AC, Daher FP, Mattioli R. H1-histamine receptors in the amygdala are involved in emotional memory but do not mediate anxiety-related behaviors in mice submitted to EPM testing. Brain Res Bull. 2012;89(1–2):1–7.10.1016/j.brainresbull.2012.06.00922772356 Search in Google Scholar